[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100309083":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":21,"locations":26,"responsibleParty":43,"collaborators":45,"id":49,"slug":7,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":7,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":7,"maxAge":7,"enrollmentInfo":56,"targetDuration":59,"studyType":60,"phases":7,"briefSummary":61,"conditions":62,"keywords":7,"overallStatus":28,"whyStopped":7,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"University of California, Los Angeles","OTHER",null,[9,13,16,19],{"name":10,"affiliation":11,"role":12},"Wen-Hann Tan, BMBS","Boston Children's Hospital","PRINCIPAL_INVESTIGATOR",{"name":14,"affiliation":15,"role":12},"Loren Pena, MD, PhD","Children's Hospital Medical Center, Cincinnati",{"name":17,"affiliation":18,"role":12},"Vandana Shashi, MD, PhD","Duke University",{"name":20,"affiliation":5,"role":12},"Bianca Russell, MD",[22],{"name":20,"role":23,"phone":24,"phoneExt":7,"email":25},"CONTACT","(310) 206-6581","ASXL-CHROMATIN-REGISTRY@mednet.ucla.edu",[27],{"facility":5,"status":28,"city":29,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"RECRUITING","Los Angeles","California","90095","United States","US",{"type":35,"coordinates":36},"Point",[37,38],-118.24368,34.05223,{"lat":38,"lon":37},[41],{"name":20,"role":23,"phone":42,"phoneExt":7,"email":25},"310-206-6581",{"type":12,"investigatorFullName":44,"investigatorTitle":20,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Bianca E. Russell, MD",[46,47,48],{"name":11,"class":6},{"name":15,"class":6},{"name":18,"class":6},"100309083",false,"NCT03303716","ASXL-Related Disorders Natural History Study","Natural History Study for the ASXL-Related Disorders and Chromatinopathies","Inclusion Criteria:\n\n* Clinical or molecular diagnosis of an ASXL related disorder\n\nExclusion Criteria:\n\n* No clinical or molecular diagnosis of an ASXL related disorder","ALL",{"count":57,"type":58},200,"ESTIMATED","20 Years","OBSERVATIONAL","A registry focused on the natural history, management and treatment of patients with Bohring-Opitz Syndrome (ASXL1), Shashi-Pena Syndrome (ASXL2) and Bainbridge-Ropers Syndrome (ASXL3).",[63,64,65,66,67,68],"Bohring-Opitz Syndrome","ASXL1 Gene Mutation","Shashi-Pena Syndrome","ASXL2 Gene Mutation","Bainbridge-Ropers Syndrome","ASXL3 Gene Mutation","2025-12-18",{"date":71,"type":72},"2025-12-26","ACTUAL",{"date":74,"type":72},"2017-09-20",{"date":76,"type":58},"2037-09",{"name":5,"class":6},1]